The offer comprises a fresh issue (| 300 crore) and offer for sale. Net Laurus Labs (Laurus) is a leading Indian active pharma ingredient (API) manufacturer having a leadership position in the therapeutic areas of antiretrovirals (ARVs or anti-AIDS) and Hepatitis C. Laurus also manufactures APIs for oncology and other therapeutic areas. In FY16, nine out of the 10 largest generic pharmaceutical companies in the world (by revenues) were its customers. In FY16, it sold APIs in 32 countries. Laurus also has synthesis and neutraceutical/cosmeceuticals ingredients businesses. The company is planning to foray into the formulation segment. Till date, the...